Cargando…

Corrigendum: The Research Progress of Direct KRAS G12C Mutation Inhibitors

Detalles Bibliográficos
Autores principales:	Yang, Ai, Li, Min, Fang, Mingzhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pathology and Oncology Archive
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908423/ https://www.ncbi.nlm.nih.gov/pubmed/35281723 http://dx.doi.org/10.3389/pore.2021.1610250

Ejemplares similares

The Research Progress of Direct KRAS G12C Mutation Inhibitors
por: Yang, Ai, et al.
Publicado: (2021)

The Advance and Correlation of KRAS Mutation With the Fertility-Preservation Treatment of Endometrial Cancer in the Background of Molecular Classification Application
por: Yu, KeXuan, et al.
Publicado: (2021)

Frequency and Clinicopathological Characteristics of Patients With KRAS/BRAF Double-Mutant Colorectal Cancer: An In Silico Study
por: Uchida, Shiro, et al.
Publicado: (2022)

Long Non-Coding RNA in Esophageal Cancer: A Review of Research Progress
por: Yang, Chenbo, et al.
Publicado: (2022)

Correlations Between the Expression of Stromal Cell Activation Related Biomarkers, L-NGFR, Phospho-ERK1-2 and CXCL12, and Primary Myelofibrosis Progression
por: Szekely, Tamas, et al.
Publicado: (2022)

Corrigendum: Comprehensive Analysis of the Expression and Prognosis for Laminin Genes in Ovarian Cancer
por: Diao, Bowen, et al.
Publicado: (2022)

Corrigendum: Case report: Potential predictive value of MMR/MSI status and PD-1 expression in immunotherapy for urothelial carcinoma
por: Ma, Yu-Ting, et al.
Publicado: (2023)

Corrigendum: Methylation Statuses of H19DMR and KvDMR at WT2 in Wilms Tumors in Taiwan
por: Lu, Meng-Yao, et al.
Publicado: (2022)

Corrigendum: Overall Survival Prediction of Advanced Cancer Patients by Selection of the Most Significant Baseline Serum Biomarker Combination
por: Deme, Daniel, et al.
Publicado: (2022)

Corrigendum: Blood, toil, and taxoteres: Biological determinants of treatment-induced ctDNA dynamics for interpreting tumor response
por: Boniface, Christopher T., et al.
Publicado: (2023)

A Novel BRD Family PROTAC Inhibitor dBET1 Exerts Great Anti-Cancer Effects by Targeting c-MYC in Acute Myeloid Leukemia Cells
por: Zhang, Kunlong, et al.
Publicado: (2022)

Identification of Co-Expression Modules and Genes Associated With Tumor Progression in Oral Squamous Cell Carcinoma
por: Fang, Zhijie, et al.
Publicado: (2022)

Corrigendum: Systemic treatment of breast cancer. 1st Central-Eastern European professional Consensus Statement on breast cancer
por: Rubovszky, Gábor, et al.
Publicado: (2023)

Evaluation of KRAS(G12C) inhibitor responses in novel murine KRAS(G12C) lung cancer cell line models
por: Sisler, Daniel J., et al.
Publicado: (2023)

Is Single Nucleotide Polymorphism ADIPOQ (NM_004797.4):c.214+62G>T (rs1501299) Associated With Uterine Leiomyomas? A Pilot Study
por: Bieńkiewicz, Jan, et al.
Publicado: (2022)

Vasculogenic Mimicry Formation Predicts Tumor Progression in Oligodendroglioma
por: Xie, Jing, et al.
Publicado: (2021)

Clinical Value of TXNDC12 Combined With IDH and 1p19q as Biomarkers for Prognosis of Glioma
por: Wang, Xinzhuang, et al.
Publicado: (2021)

Corrigendum: High Neutrophil-to-Lymphocyte Ratio (NLR) and Systemic Immune-Inflammation Index (SII) are Markers of Longer Survival After Metastasectomy of Patients With Liver-Only Metastasis of Rectal Cancer
por: Polk, Nándor, et al.
Publicado: (2022)

Editorial: In vivo and in vitro models for research in pathology
por: Tan, Songwen, et al.
Publicado: (2023)

Recent advances and future directions in etiopathogenesis and mechanisms of reactive oxygen species in cancer treatment
por: Verma, Priyanka, et al.
Publicado: (2023)

LAMP5 may promote MM progression by activating p38
por: Chen, Yan, et al.
Publicado: (2023)

HLA Class I Downregulation in Progressing Metastases of Melanoma Patients Treated With Ipilimumab
por: Ladányi, Andrea, et al.
Publicado: (2022)

Serum Tie-1 is a Valuable Marker for Predicting the Progression and Prognosis of Cervical Cancer
por: Bai, Rui, et al.
Publicado: (2021)

Somatostatin Receptor 2: A Potential Predictive Biomarker for Immune Checkpoint Inhibitor Treatment
por: Wang, Aoyun, et al.
Publicado: (2022)

Identification of a Gene Prognostic Model of Gastric Cancer Based on Analysis of Tumor Mutation Burden
por: Ma, Weijun, et al.
Publicado: (2021)

Progression Patterns in Non-Contrast-Enhancing Gliomas Support Brain Tumor Responsiveness to Surgical Lesions
por: Brenner, Steffen, et al.
Publicado: (2022)

Delayed spontaneous remission of acquired factor V inhibitor refractory to immunosuppressive therapy with pregnancy-associated improvement
por: Ceglédi, Andrea, et al.
Publicado: (2023)

GTF2I Mutation in Thymomas: Independence From Racial-Ethnic Backgrounds. An Indian/German Comparative Study
por: Jain, Deepali, et al.
Publicado: (2021)

Targeting KRAS in Lung Cancer Beyond KRAS G12C Inhibitors: The Immune Regulatory Role of KRAS and Novel Therapeutic Strategies
por: Cucurull, Marc, et al.
Publicado: (2022)

Prognostic and therapeutic impact of the KRAS G12C mutation in colorectal cancer
por: Qunaj, Lindor, et al.
Publicado: (2023)

Identification and Validation of an m6A-Related LncRNA Signature to Predict Progression-Free Survival in Colorectal Cancer
por: Zhang, Yong, et al.
Publicado: (2022)

Retraction: MiR-424-5p Inhibits Proliferation, Invasion and Promotes Apoptosis and Predicts Good Prognosis in Glioma by Directly Targeting BFAR
por: Pathology & Oncology Research Editorial Office,
Publicado: (2021)

Case report: Circulating tumor DNA technology displays temporal and spatial heterogeneity in Waldenström macroglobulinemia during treatment with BTK inhibitors
por: Zhu, Jingjing, et al.
Publicado: (2023)

Vitiligo-like lesions induced by cyclin-dependent kinase 4/6 inhibitor Palbociclib: a case report and literature review
por: Gao, Shan, et al.
Publicado: (2023)

Low-grade oncocytic tumour (LOT) of the kidney is characterised by GATA3 positivity, FOXI1 negativity and mTOR pathway mutations
por: Chen, Tongbing, et al.
Publicado: (2023)

Tumor PD-L1 expression and molecular profiling are not associated with immune checkpoint inhibitor-induced thyroid dysfunction in advanced NSCLC patients
por: Horesh, Adi, et al.
Publicado: (2023)

A new perspective on the proper timing of radiotherapy during CDK4/6 inhibitor therapy in patients with “bone-only” metastatic breast cancer
por: Tornyi, Ilona, et al.
Publicado: (2023)

The Prognostic Role of PORT and EGFR Mutation Status in Completely Resected Stage IIIA/N2 Non-Small Cell Lung Cancer Patients with Postoperative Chemotherapy
por: Yang, Hui, et al.
Publicado: (2021)

Correlation between fibroblast growth factor receptor mutation, programmed death ligand-1 expression and survival in urinary bladder cancer based on real-world data
por: Revesz, Janos, et al.
Publicado: (2023)

Pathological Changes and Expression of JAK-STAT Signaling Pathway Hallmark Proteins in Rat Retinas at Different Time Points After Retinal Ischemia Reperfusion Injury
por: Wang, Shun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vkkjqpukk749i3fn7hdm8h6tdq